Valuation models
price $149.68 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused92.85 – 126.22104.8443% overvaluedDCF · Perpetuity growth · 10y117.48 – 161.71134.1512% overvaluedP/E · peers—168.6011% undervaluedP/E · own history275.40 – 5,972.26391.6762% undervaluedPEG—162.688% undervaluedEV/EBITDA · peers—174.0814% undervaluedEV/Revenue · peers262.46 – 371.43267.1144% undervaluedWall St. consensus target—167.5011% belowCost of capital (WACC)—9.05%—
DCF · Perpetuity growth · 5y leads for a high-growth company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
104.84
Insulet closed at $149.68 — overvalued by 43% vs model.
92.85the model's range126.22
DCF · Perpetuity growth · 5y leads for a high-growth company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
134.15 – 391.67
Wall St. target
167.50 11% below
Above model, 1y
22 of 30 days
How it is valued
Valued asHigh growth
High revenue growth (~26% recent)Moderate margins (9% net margin)Highly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.